JoAnne Flynn has a Bachelor of Science degree in Biochemistry, from the University of California at Davis and a PhD from University of California at Berkeley in Microbiology and Immunology. Dr. Flynn’s first post-doc was with Dr. Magdalene So at the Scripps Clinic Research Institute and then joined the lab of Dr. Barry Bloom at Albert Einstein College of Medicine, as a Howard Hughes Research Associate, where she began her studies in tuberculosis. In 2018 she won the University of Pittsburgh School of Medicine Distinguished Mentor Award. In 2019 Dr. Flynn has been awarded the title of Distinguished Professor. Dr. Flynn directs a NIH T32 Training Program and has grants from NIH and the Bill and Melinda Gates Foundation. Her research in tuberculosis is focused on immunology, host-pathogen interactions, vaccines, and drugs, and she has developed and used non-human primate models for tuberculosis research over the past 20 years. She has multiple collaborations nationally and internationally. Dr. Flynn’s research uses cutting-edge tools and technologies to investigate the complexities of Mycobacterium tuberculosis infection, with a particular focus on lung and lymph node granulomas.